Micrographia Bio
Micrographia Bio combines imaging mass spectrometry and AI to map protein distributions in tissues. Its platform uncovers drug targets and mechanism insights at cellular resolution—accelerating therapeutic development.
Founders
Julia Li
CEO
Julia completed a PhD Engineering which focused on innovative financing solutions for global health. Stemming from her PhD research at Gates Cambridge, she originated, raised and deployed the world’s first $108 Million Global Health Investment Fund with Lion’s Head Global Partners and the Bill and Melinda Gates Foundation.
Chris Thompson
CTO
Christopher originally attended the University of Louisville and achieved a Masters in Microbiology. He went on to take a PhD at Imperial College London in Microbial Pathogenesis. He stayed in academia studying cancer research before joining a startup as an ML engineer.